CD274 and cancer: Promoter methylation inversely correlates with CD274 levels across several cancers in gastric cancer (44), diffuse low-grade glioma (45), and non-small cell lung cancer (46), hypermethylation suppresses CD274 transcription, whereas hypomethylation enhances expression and immunosuppressive activity (47).